Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

1220.54.08104 Boehringer Ingelheim Investigational Site, Chuo-ku, Chiba

1220.54.08118 Boehringer Ingelheim Investigational Site, Chuo-ku, Kobe, Hyogo

1220.54.08108 Boehringer Ingelheim Investigational Site, Fukui, Fukui

1220.54.08110 Boehringer Ingelheim Investigational Site, Gifu, Gifu

1220.54.08105 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

1220.54.08112 Boehringer Ingelheim Investigational Site, Izunokuni, Shizuoka

1220.54.08107 Boehringer Ingelheim Investigational Site, Kanazawa, Ishikawa

1220.54.08120 Boehringer Ingelheim Investigational Site, Kita-gun, Kagawa

1220.54.08109 Boehringer Ingelheim Investigational Site, Kofu, Yamanashi

1220.54.08123 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka

1220.54.08121 Boehringer Ingelheim Investigational Site, Mtsuyama, Ehime

1220.54.08113 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

1220.54.08117 Boehringer Ingelheim Investigational Site, Nishinomiya, Hyogo

1220.54.08111 Boehringer Ingelheim Investigational Site, Ogaki, Gifu

1220.54.08124 Boehringer Ingelheim Investigational Site, Oo Mura, Nagasaki,

1220.54.08115 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1220.54.08116 Boehringer Ingelheim Investigational Site, Osakasayama, Osaka

1220.54.08101 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

1220.54.08102 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1220.54.08119 Boehringer Ingelheim Investigational Site, Tanabe, Wakayama

1220.54.08106 Boehringer Ingelheim Investigational Site, Toyama,Toyama

1220.54.08114 Boehringer Ingelheim Investigational Site, Tsu, Mie

1220.54.08122 Boehringer Ingelheim Investigational Site, Yahatanishi-ku, Kitakyusyu, Fukuoka

1220.54.08125 Boehringer Ingelheim Investigational Site, Yamagata, Yamagata